These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15229526)

  • 1. US rejiggers Bioshield bill.
    Herrera S
    Nat Biotechnol; 2004 Jul; 22(7):792. PubMed ID: 15229526
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity for immunizations: tort liability, biodefense, and Bioshield II.
    Mayer L
    Stanford Law Rev; 2007 Apr; 59(6):1753-90. PubMed ID: 17593591
    [No Abstract]   [Full Text] [Related]  

  • 3. Biodefense: 10 years after. Reinventing Project BioShield.
    Cohen J
    Science; 2011 Sep; 333(6047):1216-8. PubMed ID: 21885752
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech firms pin hopes on defence.
    Pearson H
    Nature; 2003 Apr; 422(6934):790. PubMed ID: 12712154
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioterrorism. BioShield is slow to build U.S. defenses against bioweapons.
    Kaiser J
    Science; 2006 Jul; 313(5783):28-9. PubMed ID: 16825542
    [No Abstract]   [Full Text] [Related]  

  • 6. Turning biodefense dollars into products.
    Trull MC; du Laney TV; Dibner MD
    Nat Biotechnol; 2007 Feb; 25(2):179-84. PubMed ID: 17287749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US expands anti-bioterrorist measures.
    Fox JL
    Nat Biotechnol; 2001 Nov; 19(11):998-1000. PubMed ID: 11689831
    [No Abstract]   [Full Text] [Related]  

  • 8. Expanding Bioshield: a call for caution.
    May T
    Am J Public Health; 2007 Apr; 97 Suppl 1(Suppl 1):S23-5. PubMed ID: 17413075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long wait almost over. Project Bioshield measure nears final approval.
    Fong T
    Mod Healthc; 2004 Jul; 34(29):18-9. PubMed ID: 15301143
    [No Abstract]   [Full Text] [Related]  

  • 10. US budget/Bioshield initiative emphasizes bioterrorism countermeasures.
    Fox JL
    Nat Biotechnol; 2003 Mar; 21(3):216. PubMed ID: 12610554
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioterrorism--biotechnology to the rescue?
    Niiler E
    Nat Biotechnol; 2002 Jan; 20(1):21-5. PubMed ID: 11753354
    [No Abstract]   [Full Text] [Related]  

  • 12. Project Bioshield: protecting Americans from terrorism.
    Meadows M
    FDA Consum; 2004; 38(6):32-3. PubMed ID: 15675025
    [No Abstract]   [Full Text] [Related]  

  • 13. US biodefense contracts continue to lure biotechs.
    Shaffer C
    Nat Biotechnol; 2010 Mar; 28(3):187-8. PubMed ID: 20212465
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioterrorism: what level is the threat and are vaccines the answer?
    Smith LA
    Expert Rev Vaccines; 2004 Oct; 3(5):493-5. PubMed ID: 15485326
    [No Abstract]   [Full Text] [Related]  

  • 15. A defensive strategy.
    Lok C
    Nature; 2005 Oct; 437(7063):1392-3. PubMed ID: 16283702
    [No Abstract]   [Full Text] [Related]  

  • 16. BioShield defence programme set to fund anthrax vaccine.
    Check E
    Nature; 2004 May; 429(6987):4. PubMed ID: 15129240
    [No Abstract]   [Full Text] [Related]  

  • 17. Bush signs law to protect US from bioterrorism.
    Charatan F
    BMJ; 2004 Jul; 329(7460):250. PubMed ID: 15284136
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost/success projections for US biodefense countermeasure development.
    Matheny J; Mair M; Smith B
    Nat Biotechnol; 2008 Sep; 26(9):981-3. PubMed ID: 18779804
    [No Abstract]   [Full Text] [Related]  

  • 19. Biodefense. House passes plan for drug, vaccine R&D.
    Kaiser J
    Science; 2006 Oct; 314(5796):39. PubMed ID: 17023625
    [No Abstract]   [Full Text] [Related]  

  • 20. Boldness, but with realism.
    Nat Biotechnol; 2004 Aug; 22(8):927. PubMed ID: 15286627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.